MBX — MBX BIOSCIENCES INC

Ownership history in Elmind Capital, LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Elmind Capital, LP reported a position in MBX BIOSCIENCES INC (MBX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.96% (2025 Q4)
Avg. % of fund
1.96%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 211,000 — — 1.96% $6.7M $31.54
% of Fund (quarterly)    MBX price (monthly, adj. close)

Other funds also holding MBX

As of 2025 Q4 — sorted by position size

NVP Associates, LLC 3Y 26.4% NEA Management Company, LLC 3Y 7Y 5.81% Frazier Life Sciences Management, L.P. 3Y 5.64% EcoR1 Capital, LLC 3Y 7Y 3.04% Parkman Healthcare Partners LLC 3Y 2.66% ORBIMED ADVISORS LLC 3Y 7Y 2.53% Kynam Capital Management, LP 3Y 1.88% Deep Track Capital, LP 3Y 1.83% Cormorant Asset Management, LP 3Y 7Y 1.63% DAFNA Capital Management LLC 3Y 7Y 1.21%
← Back to Elmind Capital, LP Holdings